Current Therapy for Metastatic Urothelial Carcinoma

被引：5

作者：

Nadal, Rosa ^{[1
]}

Clara, Joseph A. ^{[1
]}

Valderrama, Begona P. ^{[2
]}

Bellmunt, Joaquim ^{[3
]}

机构：

[1] NHLBI, Cellular & Mol Therapeut Branch, NIH, 10 Ctr Dr,Room 3E-5330, Bethesda, MD 20892 USA

[2] Hosp Univ Virgen Rocio, Ave Manuel Siurot S-N, Seville 41001, Spain

[3] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med Oncol, 330 Brookline Ave,KS 118, Boston, MA 02215 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 03期

关键词：

Urothelial carcinoma; Systemic therapy; Immune checkpoint inhibitors; Targeted therapy; FGFR inhibitor; Antibody-drug conjugate; TRANSITIONAL-CELL CARCINOMA; PHASE-II TRIAL; GEMCITABINE PLUS CISPLATIN; COLONY-STIMULATING FACTOR; RANDOMIZED-TRIAL; OPEN-LABEL; 1ST-LINE CHEMOTHERAPY; DOUBLE-BLIND; COMBINATION CHEMOTHERAPY; WEEKLY PACLITAXEL;

D O I：

10.1016/j.hoc.2021.02.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：469 / 493

页数：25

共 126 条

[1] Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361 [J].

Alva, A. ;

Csoszi, T. ;

Ozguroglu, M. ;

Matsubara, N. ;

Geczi, L. ;

Cheng, S. Y-S. ;

Fradet, Y. ;

Oudard, S. ;

Vulsteke, C. ;

Morales Barrera, R. ;

Flechon, A. ;

Gunduz, S. ;

Loriot, Y. ;

Rodriguez-Vida, A. ;

Mamtani, R. ;

Yu, E. Y. ;

Nam, K. ;

Imai, K. ;

Moreno, B. H. ;

Powles, T. B. .

ANNALS OF ONCOLOGY, 2020, 31 :S1155-S1155

[2]

[Anonymous], FDA Grants Fast Track Designation for MediciNova's MN-166 (ibudilast) for Progressive Multiple Sclerosis

[3] Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors [J].

Apolo, Andrea B. ;

Nadal, Rosa ;

Girardi, Daniel M. ;

Niglio, Scot A. ;

Ley, Lisa ;

Cordes, Lisa M. ;

Steinberg, Seth M. ;

Sierra Ortiz, Olena ;

Cadena, Jacqueline ;

Diaz, Carlos ;

Mallek, Marissa ;

Davarpanah, Nicole N. ;

Costello, Rene ;

Trepel, Jane B. ;

Lee, Min-Jung ;

Merino, Maria J. ;

Bagheri, Mohammad Hadi ;

Monk, Paul ;

Figg, William D. ;

Gulley, James L. ;

Agarwal, Piyush K. ;

Valera, Vladimir ;

Chalfin, Heather J. ;

Jones, Jennifer ;

Streicher, Howard ;

Wright, John J. ;

Ning, Yangmin M. ;

Parnes, Howard L. ;

Dahut, William L. ;

Bottaro, Donald P. ;

Lara, Primo N., Jr. ;

Saraiya, Biren ;

Pal, Sumanta K. ;

Stein, Mark N. ;

Mortazavi, Amir .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) :3672-+

[4] Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial [J].

Apolo, Andrea B. ;

Nadal, Rosa ;

Tomita, Yusuke ;

Davarpanah, Nicole N. ;

Cordes, Lisa M. ;

Steinberg, Seth M. ;

Cao, Liang ;

Parnes, Howard L. ;

Costello, Rene ;

Merino, Maria J. ;

Folio, Les R. ;

Lindenberg, Liza ;

Raffeld, Mark ;

Lin, Jeffrey ;

Lee, Min-Jung ;

Lee, Sunmin ;

Alarcon, Sylvia V. ;

Yuno, Akira ;

Dawson, Nancy A. ;

Allette, Kimaada ;

Roy, Arpita ;

De Silva, Dinuka ;

Lee, Molly M. ;

Sissung, Tristan M. ;

Figg, William D. ;

Agarwal, Piyush K. ;

Wright, John J. ;

Ning, Yangmin M. ;

Gulley, James L. ;

Dahut, William L. ;

Bottaro, Donald P. ;

Trepel, Jane B. .

LANCET ONCOLOGY, 2020, 21 (08) :1099-1109

[5] Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study [J].

Apolo, Andrea B. ;

Infante, Jeffrey R. ;

Balmanoukian, Ani ;

Patel, Manish R. ;

Wang, Ding ;

Kelly, Karen ;

Mega, Anthony E. ;

Britten, Carolyn D. ;

Ravaud, Alain ;

Mita, Alain C. ;

Safran, Howard ;

Stinchcombe, Thomas E. ;

Srdanov, Marko ;

Gelb, Arnold B. ;

Schlichting, Michael ;

Chin, Kevin ;

Gulley, James L. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2117-+

[6] First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study [J].

Balar, Arjun V. ;

Castellano, Daniel ;

O'Donnell, Peter H. ;

Grivas, Petros ;

Vuky, Jacqueline ;

Powles, Thomas ;

Plimack, Elizabeth R. ;

Hahn, Noah M. ;

de Wit, Ronald ;

Pang, Lei ;

Savage, Mary J. ;

Perini, Rodolfo F. ;

Keefe, Stephen M. ;

Bajorin, Dean ;

Bellmunt, Joaquim .

LANCET ONCOLOGY, 2017, 18 (11) :1483-1492

[7] Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial [J].

Balar, Arjun V. ;

Galsky, Matthew D. ;

Rosenberg, Jonathan E. ;

Powles, Thomas ;

Petrylak, Daniel P. ;

Bellmunt, Joaquim ;

Loriot, Yohann ;

Necchi, Andrea ;

Hoffman-Censits, Jean ;

Perez-Gracia, Jose Luis ;

Dawson, Nancy A. ;

van der Heijden, Michiel S. ;

Dreicer, Robert ;

Srinivas, Sandy ;

Retz, Margitta M. ;

Joseph, Richard W. ;

Drakaki, Alexandra ;

Vaishampayan, Ulka N. ;

Sridhar, Srikala S. ;

Quinn, David I. ;

Duran, Ignacio ;

Shaffer, David R. ;

Eigl, Bernhard J. ;

Grivas, Petros D. ;

Yu, Evan Y. ;

Li, Shi ;

Kadel, Edward E., III ;

Boyd, Zachary ;

Bourgon, Richard ;

Hegde, Priti S. ;

Mariathasan, Sanjeev ;

Thastrom, AnnChristine ;

Abidoye, Oyewale O. ;

Fine, Gregg D. ;

Bajorin, Dean F. .

LANCET, 2017, 389 (10064) :67-76

[8] Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: A multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group [J].

Bamias, A ;

Aravantinos, G ;

Deliveliotis, C ;

Bafaloukos, D ;

Kalofonos, C ;

Xiros, N ;

Zervas, A ;

Mitropoulos, D ;

Samantas, E ;

Pectasides, D ;

Papakostas, P ;

Gika, D ;

Kourousis, C ;

Koutras, A ;

Papadimitriou, C ;

Bamias, C ;

Kosmidis, P ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :220-228

[9] Restoring function in exhausted CD8 T cells during chronic viral infection [J].

Barber, DL ;

Wherry, EJ ;

Masopust, D ;

Zhu, BG ;

Allison, JP ;

Sharpe, AH ;

Freeman, GJ ;

Ahmed, R .

NATURE, 2006, 439 (7077) :682-687

[10] The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation [J].

Bardhan, Kankana ;

Anagnostou, Theodora ;

Boussiotis, Vassiliki A. .

FRONTIERS IN IMMUNOLOGY, 2016, 7

← 1 2 3 4 5 6 7 8 9 10 →